Search the Newsreel

Lisata Therapeutics, Inc. Revenue Breakdown – MUN:8NE

Lisata Therapeutics, Inc. (MUN:8NE) generated 85.14K EUR in revenue last year. The top-performing segment was Certepetide, contributing 144.74K EUR, significantly down from 965.98K EUR the previous year. The United States was the largest regional contributor, also at 144.74K EUR, compared to 965.98K EUR in …

Globalstar, Inc. $GSAT is Ashford Capital Management Inc.'s Largest Position

Ashford Capital Management Inc. has reduced its stake in Globalstar, Inc. (NASDAQ:GSAT) by 9.2%, yet Globalstar remains its largest holding, accounting for 7.4% of its portfolio. Other institutional investors like Sculptor Capital LP and UBS Group AG have also adjusted their positions in the …

Globalstar Inc (GSAT) Shareholder Structure: Major Shareholders & Institutional Holdings

This article provides a detailed breakdown of Globalstar Inc (GSAT) shareholder structure, listing major individual and institutional holders, their proportions, and recent activity. It also categorizes shareholders by type and presents institutional shareholding trends over several quarters. Finally, it lists related ETFs that include …

Are You Looking for a Top Momentum Pick? Why Allstate (ALL) is a Great Choice

Momentum investing is all about the idea of following a stock's recent trend, which can be in either direction. In the "long context," investors will essentially be "buying high, but hoping to sell even higher." And for investors following this methodology, taking advantage of …

Lisata Therapeutics Inc (LSTA) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

This article from TradingKey attempts to provide a revenue breakdown for Lisata Therapeutics Inc (LSTA), including business segments and regional contributions. However, it explicitly states that the relevant data have not been disclosed by the company yet. Therefore, no detailed financial information regarding revenue …

237,000 Shares in Globalstar, Inc. $GSAT Purchased by Sculptor Capital LP

Sculptor Capital LP acquired 237,000 shares of Globalstar (NASDAQ:GSAT) in the first quarter, valued at approximately $15.7 million, giving it a 0.18% stake. Despite this acquisition and other institutional investor activity, analyst sentiment remains cautious with a consensus "Hold" rating and a $69 target …

Lisata Therapeutics Inc (LSTA) Valuation: PE, PB & Fair Value Analysis

Lisata Therapeutics Inc (LSTA) has a current valuation score of 6.17, placing it 351st out of 386 in the Biotechnology & Medical Research industry. Its P/E ratio stands at -0.90, which is significantly below its recent high and above its recent low. The company …

Lisata Therapeutics Inc (LSTA) Cash Flow

This article provides a detailed cash flow statement for Lisata Therapeutics Inc (LSTA), including operating, investing, and financing cash flows presented quarterly and annually. It includes historical data dating back to FY2012Q1 and defines key cash flow metrics. The data reveals various financial movements, …

Allstate stock trades steady as auto and homeowners results shape the outlook

Allstate's stock performance is influenced by balancing auto and homeowners insurance trends, with recent earnings showing profitability despite high claim costs and weather-related losses. The company's revenue growth in subsequent periods reflects effective pricing and customer retention, while its focus on underwriting adjustments and …

Allstate Corp - Detailed Introduction, Company Background, Business Scope, Financial Data, and Market Performance | TradingKey

This article provides a detailed profile of Allstate Corp (ALL), outlining its business scope in protecting against various life uncertainties through auto, home, and other personal lines of insurance, as well as protection services. It includes key company information such as ticker symbol, IPO …

Senvest Management LLC Has $57.72 Million Position in Globalstar, Inc. $GSAT

Senvest Management LLC significantly increased its stake in Globalstar, Inc. (NASDAQ:GSAT) by 27.7% in the first quarter, now holding 868,946 shares valued at $57.72 million, making it their 23rd-largest position. Other institutional investors have also adjusted their holdings, with hedge funds and institutions collectively …

Lisata Therapeutics (LSTA) Plunges 21%: Key Levels to Watch - Zero Gamma Level

Allstate Corp (ALL) Risk Assessment: Volatility, Financial Risk & Investment Risk

This article provides a risk assessment for Allstate Corp (ALL), covering various metrics related to volatility, financial risk, and investment risk. Key data points include Beta, VaR, Maximum Drawdown, Volatility, Return, Sharpe Ratio, Skewness, Downside Risk-Adjusted Return, and Liquidity measures such as Turnover Rate …

Allstate (ALL) Stock May Trade At A Discount Following Catastrophe Losses

Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. Allstate stock has delivered a strong 146.8% return over the past three years, which raises a clear tension for investors between that share …

Globalstar Inc (GSAT) Income Statement

This article provides a detailed historical income statement for Globalstar Inc (GSAT), covering quarterly and annual performance metrics such as total revenue, cost of revenue, operating expenses, and net income, dating back to FY2012Q1. It also includes key financial figures for recent periods, such …

Allstate Corp (ALL) - Tradingkey Stock Score & Comprehensive Stock Analysis

This article provides a comprehensive stock analysis of Allstate Corp (ALL) by TradingKey, assigning it a stock score based on various financial indicators. It details the company's strengths, risks, and its ranking within the insurance industry. The analysis also includes institutional confidence, analyst ratings, …

Is Allstate (ALL) Fairly Valued After Bullish Analyst Revisions Ahead Of Earnings?

Lisata Therapeutics Shares Fall After Terminating Kuva Labs Deal

Lisata Therapeutics announced the termination of its acquisition agreement with Kuva Labs, effective July 25, 2026. Following this news, the company's shares experienced a significant decline of over 26% during premarket trading. The deal's termination indicates a change in strategic direction or unfulfilled conditions …

Allstate Corporation (The) Revenue Breakdown – NYSE:ALL

The Allstate Corporation (ALL) generated a total revenue of $59.55 billion USD last year. The primary revenue driver was its Allstate Protection segment, contributing $59.73 billion USD. The majority of this revenue, $64.86 billion USD, originated from the United States.

GSAT|Globalstar Inc|Price:78.930|Chg%:-0.260

Globalstar Inc (GSAT) closed at $78.930 with a slight decrease of 0.33%. The company's fundamentals are robust with high growth potential, and it is considered fairly valued within the Telecommunications Services industry. Analysts maintain a "Buy" rating with a target price of $85.00, suggesting …

Globalstar, Inc. Revenue Breakdown – SWB:P8S0

Globalstar, Inc. generated 232.43 million EUR in revenue last year, with its top-performing segment, Service - Wholesale Capacity, contributing 147.07 million EUR. The United States was the largest regional contributor, accounting for 202.76 million EUR. This data provides a breakdown of the company's revenue …

Lisata Therapeutics Terminates Merger Agreement With Kuva Labs On July 24, Says SEC Filing

Lisata Therapeutics announced the termination of its merger agreement with Kuva Labs on July 24, according to a recent SEC filing. The news was reported by Reuters and indicates a change in the strategic plans for both companies.

ALL or WRB: Which Is the Better Value Stock Right Now?

Investors looking for stocks in the Insurance - Property and Casualty sector might want to consider either Allstate (ALL) or W.R. Berkley (WRB). But which of these two stocks offers value investors a better bang for their buck right now? We'll need to take …

Lisata Therapeutics Inc (LSTA) Institutional Confidence

Lisata Therapeutics Inc (LSTA) has an institutional shareholding score of 3.00, placing it 192nd in the Biotechnology & Medical Research industry. This score reflects a 10.92% institutional shareholding proportion, which increased by 34.03% quarter-over-quarter. James Simons is the largest institutional shareholder, holding 1.46% of …

Allstate (ALL) Rises As Market Takes a Dip: Key Facts

Allstate (ALL) ended the recent trading session at $254.52, demonstrating a +1.07% change from the preceding day's closing price. The stock exceeded the S&P 500, which registered a loss of 1.21% for the day. At the same time, the Dow lost 0.97%, and the …

Allstate Corp. stock underperforms Thursday when compared to competitors despite daily gains

Shares of Allstate Corp. (ALL) rose by 1.07% to $254.52 on Thursday, despite a general market downturn where the S&P 500 Index and Dow Jones Industrial Average both fell. Despite this daily gain, the stock underperformed when compared to its competitors. This marks the …

Allstate stock consolidates as underwriting margins improve and catastrophe exposure stays in focus

Allstate Corp. (US0200021014) stock performance is influenced by improving underwriting margins and persistent catastrophe exposure. The company has shown better core underwriting results and premium growth, driven by rate increases and strategic actions, but still faces volatility from severe weather events. Allstate is actively …

Allstate and U.S. Men's National Team midfielder Tyler Adams unveil mini-pitch in Atlanta to expand youth access to soccer

New community space empowers South Fulton families to connect through sport as soccer excitement builds nationwide Key takeaways: Allstate, in partnership with the U.S. Soccer Foundation and U.S. Men's National Team midfielder Tyler Adams, unveiled a new mini-pitch at Sandtown Park in South Fulton, …

Lisata Therapeutics Stock Falls After Hours: Here's Why

Lisata Therapeutics (LSTA) shares fell in after-hours trading after the company revealed that the buyer, Kuva Acquisition Corp., was unable to fund its tender offer to acquire Lisata. Approximately 66.8% of Lisata's outstanding common stock had been tendered, meeting the minimum condition for the …

ETFs Investing in Allstate Corporation Depositary Shs Repr 1/1000th 5.1% Non-Cum Red Perp Pfd Series H Stocks

This article lists several ETFs that hold Allstate Corporation Depositary Shares (ALL/PH), representing a 1/1,000th interest in Fixed Rate Noncumulative Perpetual Preferred Stock, Series H. The ETFs are sorted by their market value of these holdings and include information such as issuer, management style, …

DEMIRE secures the UN as a tenant for around 10,000 m² in Bonn

DEMIRE Deutsche Mittelstand Real Estate AG DEMIRE secures the UN as a tenant for around 10,000 m² in Bonn Langen, 21 July 2026. DEMIRE Deutsche Mittelstand Real Estate AG (ISIN: DE000A0XFSF0) has signed a lease agreement with the Institute for Federal Real Estate (BImA) …

Are Finance Stocks Lagging Allstate (ALL) This Year?

The Finance group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Has Allstate (ALL) been one of those stocks this year? Let's take a closer look at the stock's year-to-date performance to find out. …

Are Investors Undervaluing Allstate (ALL) Right Now?

Here at Zacks, we focus on our proven ranking system, which places an emphasis on earnings estimates and estimate revisions, to find winning stocks. But we also understand that investors develop their own strategies, so we are constantly looking at the latest trends in …

Lisata Therapeutics (LSTA) says Kuva tender meets conditions but financing not yet secured

Allstate pauses 3% below its high as P&C demand broadens but RS breadth stays selective

The insurer’s weekly Trend Signal remains active after a 21-week run, but the latest 0.7% slip on above-average volume leaves confirmation more measured than emphatic.

If You Invested $1000 in Allstate a Decade Ago, This is How Much It'd Be Worth Now

For most investors, how much a stock's price changes over time is important. Not only can it impact your investment portfolio, but it can also help you compare investment results across sectors and industries. FOMO, or the fear of missing out, also plays a …